KURA Kura Oncology, Inc. gains 33% Sep 4, 2020
Developing in-licensed protein inhibitors for solid tumors and blood cancers.http://www.priceseries.com/trade/KURA-Kura-Oncology-Inc-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2020080420200904.html